Investment Funds

Blue Chip Fund

The Global Blue Chip Fund is a direct equity fund that invests into approximately 25 multinational businesses, each of which is aligned with one or more of our investment themes.

Our selection process identifies financially strong and prudent businesses, which are built on growing global revenue streams and brands that you trust, as well as strong management teams who are focused on increasing shareholder value. We intend to invest into these companies for the long-term, allowing for the combination of our themes and the quality of the companies to generate returns for our investors.

 

Fund Details

Latest NAV
'I Class' – "Institutional Class" is designed for intermediaries.
"O Class" - "Ordinary Class" is designed for private clients and is the class with the lowest fee.
"ACC = Accumulation" - dividends are automatically reinvested into the fund
"DIST = Distribution" - dividends are paid out twice yearly
I Acc - £231.27
I Dist - £196.73
O Acc - £237.67
O Dist - £202.85
Annual Management Fee
'I Class' – "Institutional Class" is designed for intermediaries.
"O Class" - "Ordinary Class" is designed for private clients and is the class with the lowest fee.
"ACC = Accumulation" - dividends are automatically reinvested into the fund
"DIST = Distribution" - dividends are paid out twice yearly
I Acc Class - 1%
I Dist Class - 1%
O Acc Class - 0.75%
O Dist Class - 0.75%
  • Performance Chart
  • Performance Analysis
    1 Year 3 Year 5 Year Inception (30 June 2014) Annual Compound Growth Rate
    4.1% 11.4% 44% 139.9% 8.8%

  • Asset Weightings
    • Thematic Exposure
      • 33 Global Brands
      • 32 Healthcare
      • 29 Technology & Innovation
      • 6 Cash & Equivalents
  • Portfolio Breakdown
    Portfolio Breakdown
    Cash 6.6%
    Bruker 4.7%
    Oracle 4.3%
    GlaxoSmithKline Plc 4.2%
    Bio-Rad Laboratories 4.1%
    Walt Disney 4.1%
    Sanofi 4%
    Regeneron Pharmaceuticals 3.9%
    Ebay 3.6%
    Adobe 3.5%
    AirBNB 3.5%
    Johnson & Johnson 3.4%
    Visa Inc 3.1%
    Edwards Lifescience 3%
    Microsoft 3%
    PTC 3%
    Rockwell 3%
    WPP 3%
    Heineken 2.9%
    Solventum 2.9%
    Netflix 2.8%
    Etsy 2.6%
    Nike 2.6%
    Haleon 2.5%
    BMW 2.4%
    Diageo 2.4%
    LVMH 2.4%
    Stellantis 2.4%
    Estee Lauder 2.2%
    ASML 2.1%
    Alnylam Pharmaceuticals 1.9%

Our Investment Process

We invest into global trends and themes that we believe will benefit from these long-term changes. These are not passing trends or fads, but ongoing phenomena supported by independent evidence.  

Learn more